Cart
sales@molnova.com
Bevantolol hydrochloride
CAS No. 42864-78-8
Bevantolol hydrochloride( NC-1400 hydrochloride )
Catalog No. M21186 CAS No. 42864-78-8
Bevantolol hydrochloride is a β1-adrenoceptor antagonist that treatment angina pectoris and hypertension.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 25MG | 39 | In Stock |
|
| 50MG | 54 | In Stock |
|
| 100MG | 86 | In Stock |
|
| 200MG | 127 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBevantolol hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionBevantolol hydrochloride is a β1-adrenoceptor antagonist that treatment angina pectoris and hypertension.
-
DescriptionBevantolol hydrochloride is a β1-adrenoceptor antagonist that treatment angina pectoris and hypertension.(In Vitro):Bevantolol hydrochloride has a pKi of 6.23 for β2-adrenergic receptor.(In Vivo):Bevantolol hydrochloride (200 mg/kg; PO by water; for 6 weeks) produces a significant decrease in the expression level of β1 adrenoceptor mRNA.
-
In VitroBevantolol hydrochloride has a pKi of 6.23 for β2-adrenergic receptor.
-
In VivoBevantolol hydrochloride (200 mg/kg; PO by water; for 6 weeks) produces a significant decrease in the expression level of β1 adrenoceptor mRNA. Animal Model:Male Wistar rats weighing 250-300 g Dosage:200 mg/kg Administration:PO by water; for 6 weeks Result:Produced a significant decrease in the expression level of β1 adrenoceptor mRNA.
-
SynonymsNC-1400 hydrochloride
-
PathwayAngiogenesis
-
TargetAdrenergic Receptor
-
Recptorβ1-adrenoceptor
-
Research AreaCardiovascular Disease
-
IndicationEssential hypertension
Chemical Information
-
CAS Number42864-78-8
-
Formula Weight381.9
-
Molecular FormulaC20H28ClNO4
-
Purity>98% (HPLC)
-
SolubilityDMSO:76 mg/mL (199.01 mM)Ethanol:61 mg/mL (159.73 mM)H2O:52 mg/mL (136.16 mM)
-
SMILESCOc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Noshiro T Miura Y Yoshinaga K et al. Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan[J]. International Journal of Clinical Pharmacology & Therapeutics 1995 33(4):240-245.
molnova catalog
related products
-
AGN192836
AGN192836 (AGN 192836) is a potent, selective α2 adrenergic (alpha 2-adrenoceptor) agonist with EC50 of 8.7, 41 and 6.6 nM for α2A, α2B and α2C receptor, respectively.
-
Practolol
Practolol is a selective β-adrenoceptor blocker.
-
(R)-Terazosin
(R)-Terazosin is an active R-enantiomer of Terazosin. (R)-Terazosin is a potent antagonist of α1-adrenoceptor (α1a, α1b and α1d-adrenoceptor with Ki values of 6.51 nM, 1.01 nM and 1.97 nM, respectively).
